TVTX logo

Travere Therapeutics, Inc. Common Stock


TVTX: Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.


Show TVTX Financials

Consumer Interest
SEC Filings

Recent trades of TVTX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by TVTX's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Biphenyl sulfonamide compounds for the treatment of type iv collagen diseases Dec. 28, 2021
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of TVTX in WallStreetBets Daily Discussion


Recent insights relating to TVTX

CNBC Recommendations

Recent picks made for TVTX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in TVTX

Corporate Flights

Flights by private jets registered to TVTX